Does Vildagliptin Affect Portal Vein Pressure In Patients With Type 2 Diabetes Mellitus? A Cross Sectional Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This study investigated how vildagliptin (a di-peptidyl peptidase 4 inhibitor) affects portal vein pressure and hepatosteatosis in patients with type 2 diabetes mellitus.
Epistemonikos ID: b5630a37f441038b962fe908db9934aa7e670156
First added on: May 11, 2024